A detailed history of Ghost Tree Capital, LLC transactions in Savara Inc stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 725,000 shares of SVRA stock, worth $2.13 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
725,000
Previous 1,050,876 31.01%
Holding current value
$2.13 Million
Previous $4.24 Million 27.41%
% of portfolio
1.15%
Previous 1.73%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.96 - $5.07 $1.29 Million - $1.65 Million
-325,876 Reduced 31.01%
725,000 $3.07 Million
Q2 2024

Aug 14, 2024

SELL
$3.66 - $5.34 $2.01 Million - $2.93 Million
-549,124 Reduced 34.32%
1,050,876 $4.24 Million
Q1 2024

May 15, 2024

BUY
$4.19 - $5.59 $3.56 Million - $4.75 Million
850,000 Added 113.33%
1,600,000 $7.97 Million
Q4 2023

Feb 14, 2024

BUY
$3.18 - $4.9 $2.39 Million - $3.68 Million
750,000 New
750,000 $3.53 Million

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $335M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.